Literature DB >> 24041943

Angiotensin II-independent angiotensin-(1-7) formation in rat hippocampus: involvement of thimet oligopeptidase.

Marilia G A G Pereira1, Laura L Souza, Christiane Becari, Diego A Duarte, Fabio R B Camacho, José Antônio C Oliveira, Marcelo D Gomes, Eduardo B Oliveira, Maria Cristina O Salgado, Norberto Garcia-Cairasco, Claudio M Costa-Neto.   

Abstract

The involvement and relevance of the renin-angiotensin system have been established clearly in cardiovascular diseases, and renin-angiotensin system involvement has also been investigated extensively in the central nervous system. Angiotensin II acts classically by binding to the AT1 and AT2 receptors. However, other pathways within the renin-angiotensin system have been described more recently, such as one in which angiotensin-(1-7) (Ang-(1-7)) binds to the receptor Mas. In the central nervous system specifically, it has been reported that this heptapeptide is involved in learning and memory processes that occur in central limbic regions, such as the hippocampus. Therefore, this prompted us to investigate the possible role of the Ang-(1-7)-receptor Mas pathway in epileptic seizures, which are also known to recruit limbic areas. In the present study, we show that Ang-(1-7) is the main metabolite of angiotensin I in rat hippocampi, and, strikingly, that thimet oligopeptidase is the main enzyme involved in the generation of Ang-(1-7). Furthermore, elevations in the levels of thimet oligopeptidase, Ang-(1-7), and of receptor Mas transcripts are observed in chronically stimulated epileptic rats, which suggest that the thimet oligopeptidase-Ang-(1-7)-receptor Mas axis may have a functional relevance in the pathophysiology of these animals. In summary, our data, which describe a new preferential biochemical pathway for the generation of Ang-(1-7) in the central nervous system and an increase in the levels of various elements of the related thimet oligopeptidase-Ang-(1-7)-receptor Mas pathway, unveil potential new roles of the renin-angiotensin system in central nervous system pathophysiology.

Entities:  

Keywords:  angiotensin-(1–7); angiotensin-(1–7) receptor Mas; angiotensins; central nervous system; renin–angiotensin system; thimet oligopeptidase

Mesh:

Substances:

Year:  2013        PMID: 24041943     DOI: 10.1161/HYPERTENSIONAHA.113.01613

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  13 in total

1.  Evidence for a mitochondrial angiotensin-(1-7) system in the kidney.

Authors:  Bryan A Wilson; Manisha Nautiyal; TanYa M Gwathmey; James C Rose; Mark C Chappell
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-23

Review 2.  The ins and outs of angiotensin processing within the kidney.

Authors:  Bryan A Wilson; Allyson C Marshall; Ebaa M Alzayadneh; Mark C Chappell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-18       Impact factor: 3.619

Review 3.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

4.  Evidence for an angiotensin-(1-7) neuropeptidase expressed in the brain medulla and CSF of sheep.

Authors:  Allyson C Marshall; Nancy T Pirro; James C Rose; Debra I Diz; Mark C Chappell
Journal:  J Neurochem       Date:  2014-04-19       Impact factor: 5.372

Review 5.  Beta-Arrestins in the Treatment of Heart Failure Related to Hypertension: A Comprehensive Review.

Authors:  Ahmed Rakib; Taslima Akter Eva; Saad Ahmed Sami; Saikat Mitra; Iqbal Hossain Nafiz; Ayan Das; Abu Montakim Tareq; Firzan Nainu; Kuldeep Dhama; Talha Bin Emran; Jesus Simal-Gandara
Journal:  Pharmaceutics       Date:  2021-06-05       Impact factor: 6.321

Review 6.  Update on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways.

Authors:  Mark C Chappell; Allyson C Marshall; Ebaa M Alzayadneh; Hossam A Shaltout; Debra I Diz
Journal:  Front Endocrinol (Lausanne)       Date:  2014-01-09       Impact factor: 5.555

7.  Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy.

Authors:  Larissa B Teixeira; Lucas T Parreiras-E-Silva; Thiago Bruder-Nascimento; Diego A Duarte; Sarah C Simões; Rafael M Costa; Deisy Y Rodríguez; Pedro A B Ferreira; Carlos A A Silva; Emiliana P Abrao; Eduardo B Oliveira; Michel Bouvier; Rita C Tostes; Claudio M Costa-Neto
Journal:  Sci Rep       Date:  2017-09-19       Impact factor: 4.379

8.  ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Charles E Evans; James S Miners; Giulia Piva; Christine L Willis; David M Heard; Emma J Kidd; Mark A Good; Patrick G Kehoe
Journal:  Acta Neuropathol       Date:  2020-01-25       Impact factor: 15.887

9.  Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.

Authors:  Ikram Omar Osman; Cléa Melenotte; Philippe Brouqui; Matthieu Million; Jean-Christophe Lagier; Philippe Parola; Andréas Stein; Bernard La Scola; Line Meddeb; Jean-Louis Mege; Didier Raoult; Christian A Devaux
Journal:  Front Immunol       Date:  2021-06-14       Impact factor: 7.561

10.  Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function.

Authors:  Xiao-Li Wang; Jun Iwanami; Li-Juan Min; Kana Tsukuda; Hirotomo Nakaoka; Hui-Yu Bai; Bao-Shuai Shan; Harumi Kan-No; Masayoshi Kukida; Toshiyuki Chisaka; Toshifumi Yamauchi; Akinori Higaki; Masaki Mogi; Masatsugu Horiuchi
Journal:  NPJ Aging Mech Dis       Date:  2016-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.